Listen to the full audio podcast episode:
Watch other videos from this interview:
Rebekah Martin, senior VP of reward, inclusion, and talent acquisition at AstraZeneca, discusses workforce trends in pharma and fostering an environment for psychological safety in this Pharmaceutical Executive Podcast video.
Across most industries, finding and keeping the right talent is a constant challenge for companies. This challenge is perhaps even more prevalent in the pharmaceutical industry, which requires a significant amount of specialization.
Rebekah Martin, senior VP of reward, inclusion, and talent acquisition for AstraZeneca, discusses recruiting talent in pharma with Meg Rivers, managing editor. Specifically, Martin talks about:
Listen to the full audio podcast episode:
Watch other videos from this interview:
Rebekah Martin is the senior vice president of reward, inclusion, and talent acquisition for AstraZeneca. Martin has a master’s degree in molecular and cellular biochemistry from the University of Oxford and went on to qualify as a lawyer in the UK, joining AstraZeneca in 2011. Since joining, she has held a number of progressively senior roles in the legal team based in the UK and Singapore. She moved to her current role in the HR team in April 2018, where she leads the team responsible for reward strategy, design, and governance at AstraZeneca, talent acquisition, and leads the implementation of AstraZeneca’s global inclusion and diversity strategy. Martin is passionate about breaking down the stigma that can be associated with neurodiversity and believes there is a strong connection between diversity of thought, innovation, and performance.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.